YOLFTbeta
Kontigo Care AB

Kontigo Care AB

KONT · ST · Healthcare / Health Information Services

1.36SEK+0.23 (+19.82%)

Price History

Full chart

Market Stats

Previous Close1.14
Open1.36
Day Range1.36 – 1.36
52-Week Range1.17 – 2.43
Volume0
Market Cap44.59M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.09
Dividend Yield0.00%
Beta-0.21
50-Day Avg1.38
200-Day Avg1.59

About

Kontigo Care AB (publ) provides health care solutions for addiction treatment in Sweden. It offers Previct Care, a digital healthcare platform for treatment and follow-up of addictive diseases; and Previct Safety for real-time digital drug testing. The company was incorporated in 2013 and is based in Uppsala, Sweden.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Alexander Stendahl
  • Employees11
  • HeadquartersBangårdsgatan 4A, Uppsala, Sweden, 753 20, Sweden
  • Websitehttps://www.kontigocare.com

Leadership

  • Mr. Alexander StendahlCEO & Director · b. 1975
  • Mr. Peter LarssonChief Financial Officer · b. 1969
  • Ms. Anja Peters OhlssonConsultant · b. 1970

Financials

Income Statement

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue5.48M2.60K1.08M6.23M13.23M17.62M20.38M24.54M28.43M28.95M30.24M29.13M
Growth (%)--99.95%+41523.73%+475.79%+112.30%+33.16%+15.68%+20.44%+15.86%+1.80%+4.45%-3.66%
Cost of Revenue-5.35M-8.75M54.15K119.96K82.25K227.46K369.25K384.10K196.00K232.00K-9.85M-7.43M
Gross Profit10.83M8.75M1.03M6.11M13.15M17.39M21.96M26.95M35.97M28.72M40.08M36.56M
Gross Margin197.54%336561.62%95.00%98.07%99.38%98.71%107.76%109.80%126.50%99.20%132.56%125.51%
Operating Expense12.02M22.99M20.25M20.13M19.73M18.58M23.06M28.06M33.07M28.66M39.21M38.68M
Operating Income-1.19M-14.24M-19.22M-14.02M-6.58M-1.19M-1.10M-1.11M2.90M52.00K874.00K-2.12M
Operating Margin-21.72%-547659.81%-1775.98%-225.02%-49.75%-6.77%-5.42%-4.51%10.20%0.18%2.89%-7.27%
EBITDA-1.19M-14.24M-17.28M-11.62M-4.07M-945.01K2.20M2.67M6.82M3.92M5.07M3.57M
EBITDA Margin-21.71%-547623.08%-1596.51%-186.41%-30.79%-5.36%10.79%10.86%23.98%13.54%16.75%12.27%
Net Income-1.21M-14.29M-19.63M-14.37M-6.72M-1.58M-1.28M-1.20M2.90M212.00K775.00K-2.07M
Net Income Margin-21.99%-549434.92%-1813.87%-230.54%-50.81%-8.96%-6.30%-4.89%10.18%0.73%2.56%-7.12%
R&D---2.36M2.56M1.66M1.94M2.78M7.72M2.69M3.52M-
R&D as % of Total Revenue---37.91%19.39%9.44%9.52%11.34%27.15%9.31%11.65%-
Interest Expense15.54K47.11K410.41K345.28K151.31K135.21K89.94K46.63K10.00K292.00K433.00K160.00K
Interest Expense % of Total Revenue0.28%1811.85%37.92%5.54%1.14%0.77%0.44%0.19%0.04%1.01%1.43%0.55%

Balance Sheet

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.73M18.39M25.83M24.73M26.85M24.75M24.46M29.20M31.39M49.77M67.74M62.12M
Total Liabilities2.72M6.42M7.61M9.49M9.13M8.12M9.07M10.74M9.98M19.05M15.42M11.62M
Total Equity5.01M11.97M18.22M15.24M17.72M16.63M15.40M18.46M21.40M30.72M52.32M50.50M
Cash1.56M1.34M10.24M7.84M8.85M5.68M4.94M8.48M5.74M9.85M21.86M14.95M
Total Debt472.22K291.67K3.50M3.21M2.51M2.20M1.37M5.02M-5.95M3.67M-
Net Debt-1.09M-1.05M-6.74M-4.63M-6.34M-3.48M-4.40M-8.48M-5.74M-3.90M-18.19M-14.95M

Cash Flow

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow826.79K-12.88M-19.38M-10.56M-4.87M666.68K3.99M4.61M7.30M5.97M4.61M5.00M
Investing Cash Flow-5.48M-10.57M-563.03K-2.93M-2.62M-3.28M-3.74M-4.34M-9.50M-16.73M-10.70M-8.24M
Financing Cash Flow6.22M23.23M28.84M11.09M8.50M-560.14K-987.76K3.27M-540.00K14.87M18.11M-3.67M
Capital Expenditure5.48M10.57M563.03K2.93M2.62M3.28M3.74M4.34M9.50M15.04M10.21M8.24M
Free Cash Flow-4.66M-23.44M-19.95M-13.49M-7.49M-2.61M248.43K272.26K-2.20M-9.07M-5.61M-3.24M
FCF to OCF-563.25%182.06%102.90%127.73%153.67%-391.85%6.23%5.91%-30.10%-151.83%-121.61%-64.78%

Earnings

Report DateJun 30, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 31, 2016Nov 30, 2016Mar 1, 2017May 15, 2017Aug 12, 2017Nov 6, 2017Feb 5, 2018May 7, 2018Aug 27, 2018Oct 29, 2018Feb 4, 2019May 10, 2019Aug 21, 2019Nov 13, 2019Feb 7, 2020May 15, 2020Aug 21, 2020Nov 13, 2020Feb 5, 2021May 21, 2021Aug 27, 2021Nov 19, 2021Mar 28, 2022May 20, 2022Aug 26, 2022Nov 18, 2022Feb 3, 2023May 15, 2023Aug 22, 2023Oct 25, 2023Feb 2, 2024May 13, 2024Aug 20, 2024Nov 11, 2024Jan 31, 2025May 12, 2025Aug 19, 2025Nov 10, 2025
EPS Estimate--------0.30-0.22-0.12-0.13-0.13------------------------------
EPS Actual-0.97-0.45-0.31-0.70-0.96-0.40-0.33-0.26-0.29-0.11-0.13-0.17-0.09-0.04-0.07-0.04-0.03-0.000.00-0.03-0.030.01-0.00-0.02-0.030.01-0.020.010.050.060.01-0.02-0.020.06-0.010.000.020.02-0.02-0.02-0.040.03
Surprise-------13.33%-31.82%8.33%0.00%-30.77%------------------------------
Timing-------Pre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap44.59M
Enterprise Value31.88M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.51
Price / Book0.91
EPS-0.09
Book Value1.41
Revenue (TTM)29.56M
Gross Profit (TTM)33.28M
EBITDA-392.00K
Profit Margin-3.33%
Operating Margin-14.88%
Return on Equity-1.96%
Return on Assets-1.05%
Shares Outstanding35.25M
Shares Float18.06M
Beta-0.21
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 20, 201626:23